BeStock  
Stocks › Biotechnology › HRMY

Harmony Biosciences HRMY

US equityMarket cap rank #2704Biotechnology
$32.59 −$0.39 (-1.18%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.59 0.00%
Open$32.68
Prev close$32.98
Day range$32.51 – $33.43
Volume582.6K
Market cap$1.91B
P/E (TTM)10.8
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings11.2x
CheapRich

Near the bottom of its 5-year range · 17th percentile, 5-year average 20.4x

#749 of 2993 stocks by PE (1 = cheapest)

Price / book1.8x
CheapRich

Near the bottom of its 5-year range · 1st percentile, 5-year average 5.6x

#2920 of 5330 stocks by PB (1 = cheapest)

Price / sales2.0x
CheapRich

Near the bottom of its 5-year range · 6th percentile, 5-year average 4.3x

#2552 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-46x2x49x96xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$35.60
Price vs. fair value-8.5%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyMedium
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.85 – 5.56 1% (cheaper than usual) #2920 of 5330 (1 = cheapest)
PE 11.18 8.00 20.44 17% (cheaper than usual) #749 of 2993 (1 = cheapest)
PS 2.00 1.71 4.32 6% (cheaper than usual) #2552 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on HRMY.

Sign in to join the discussion.

Scroll to Top